2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92547°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
ÁÖÇÑ¿µ±¹¹®È­¿ø, ÁÖ¸» ¡®IELTS ÄÄÇ»ÅÍ ½ÃÇ衯 Ưº°°¡ Á¦°ø (2024-09-06)
HDÇö´ëÀÎÇÁ¶óÄÚ¾î, ¿£Áø¡¤¹èÅ͸® »ç¾÷ Ű¿î´Ù (2024-12-27)
¿¹½º24, ¹Ì·¡¸¦º¸´Ù¿Í MOU¡¦ Æ÷Å䯼ÄÏ¿¡ AR±â¼ú µµÀÔ (2024-07-29)
ÀÇ·á ¸¶À̵¥ÀÌÅÍ ¾ÕµÎ°í À¶ÇÕµ¥ÀÌÅÍ È°¿ë ±â¼ú°³¹ß °¡¼Ó (2024-12-01)
¾×Ƽ¾ð vs ±×¶û ÄÝ·¹¿À½º¡¦ÁßÇü SUV ¸Â´ë°á °á°ú´Â? (2024-09-20)
Å©¸®½º, ¡®Ý« ¼ÒÀ¯¡¯ ¹Ì³×¼ÒŸ 46¸¸Æò ¶¥ Åõ¾î 2ź (2024-09-20)
Çö´ëÂ÷, ¼ö¼ÒÀü±â Åë±Ù¹ö½º µµÀÔ È®´ë ÃßÁø (2025-01-23)
KGM, ¿¬¸»¿¬½Ã ´Ù¾çÇÑ À̺¥Æ® ÁøÇà∙∙∙ ÆÇ¸Å ... (2024-12-15)
¡®¼±ÅÃÀû ±Ý¼Ó ¹Ú¸· ÁõÂø ±â¼ú¡¯ °³¹ß (2024-09-02)
9¿ù ¼­¿ï, ¼¼°èÀÎÀÌ ÁÖ¸ñÇÏ´Â ¡®¹Ì¼úµµ½Ã¡¯·Î º¯½ÅÇÑ´Ù (2024-09-02)
The Nishi-Shinjuku Illumination Market Lighting Ceremony, a ... (2024-12-16)
¡®³ª´Â SOLO' Áö°¢ Á÷Áø ·Î¸Ç½ºÀÇ °á°ú´Â? (2024-11-07)
³²¾çÁÖ ºÀ¼±»ç¿¡¼­ '¹Ý·Á°ß°ú ÇÔ²²ÇÏ´Â ¼±¸í»ó ÃàÁ¦' °³ÃÖ (2024-09-29)
¼¿¸®µå Äڷγª19 ¹é½Å Ç׿ø Ç÷§Æû ±â¼ú, ÀϺ» ƯÇã µî·Ï (2024-12-23)
Xsolla to Present Global Expansion Solutions at Tokyo Game S... (2024-10-26)
BYD ű¹ °øÀå Áذø ¹× 8¹é¸¸ ´ë° ½Å¿¡³ÊÁö Â÷·® Ãâ°í (2024-07-27)
Àü°ø ´ëÇлý°ú ÇÔ²²Çϴ û¼Ò³â µðÁöÅÐ ±³À° Ä·ÇÁ (2024-08-09)
ÇѽÄÁøÈï¿ø, ¡®2024 µµ³ó»ó»ý Áö¿ªÆ¯»êǰ È«º¸°ü¡¯ ¿î¿µ (2024-09-17)
GS25, 5°³¿ù ¸¸¿¡ °íÇÇÀÚ ¿î¿µ ¸ÅÀå 1000È£Á¡ µ¹ÆÄ (2024-10-13)
¿¡µàÀÎÅ×Å©, Áø·Î ÄÁ¼³ÆÃ Çõ½Å... °í¾ç IR ´ëȸ¿¡¼­ ÁÖ¸ñ¹Þ¾Æ (2024-12-17)
Æ®·ÎÆ® °¡¼ö Ãִ뼺, ½Ì±Û ¡®¾îÀ̰¡ ¾ø³×¡¯ ¹ß¸Å (2024-12-17)
NetApp¡¯s 2024 Data Complexity Report Reveals AI¡¯s Make or ... (2024-12-30)
Seoul Metropolitan Youth Center Remembers 2024 Achievements ... (2024-12-30)
Á¦³×½Ã½º ÈÄ¿ø ½Å°³³ä ½ºÅ©¸° °ñÇÁ ¸®±× ¡®TGL¡¯ °ø½Ä °³¸· (2025-01-12)
Zeitview Secures $60M to Advance AI-Powered Inspections of G... (2025-03-18)
       [ÀÌÀü][1]....[408][409][410][411][412][413][414][415][416]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..